Catherine Dollfus

Summary

Country: France

Publications

  1. ncbi request reprint Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF/ANRS CO10)
    C Dollfus
    Assistance Publique Hopitaux de Paris AP HP, Service d hématologie et d oncologie pédiatrique, Hopital d Enfants Armand Trousseau, Le Kremlin Bicetre, France
    Clin Infect Dis 51:214-24. 2010
  2. doi request reprint Correction of facial lipoatrophy using autologous fat transplants in HIV-infected adolescents
    C Dollfus
    Hopital Trousseau, Paris, France
    HIV Med 10:263-8. 2009
  3. ncbi request reprint [The role of chelating agents in childhood lead poisoning]
    Catherine Dollfus
    Service d hématologie et d oncologie pédiatrique, hôpital d enfants Armand Trousseau 75571 Paris Cedex 12
    Rev Prat 58:869-70. 2008
  4. doi request reprint Prevention of mother-to-child HIV transmission: similar access for sub-Sahara African immigrants and for French women?
    Carine Jasseron
    INSERM Unit 822, Le Kremlin Bicetre, Paris, France
    AIDS 22:1503-11. 2008
  5. doi request reprint No relation between in-utero exposure to HAART and intrauterine growth retardation
    Nelly Briand
    INSERM, U822, Le Kremlin Bicetre, France
    AIDS 23:1235-43. 2009
  6. doi request reprint Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?
    Jeanne Sibiude
    CESP INSERM U1018, Le Kremlin Bicetre, Colombes, France
    Clin Infect Dis 54:1348-60. 2012
  7. ncbi request reprint Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort
    Josiane Warszawski
    INSERM, U822, IFR 60, Le Kremlin Bicetre, France
    AIDS 22:289-99. 2008
  8. pmc Perinatal acquisition of drug-resistant HIV-1 infection: mechanisms and long-term outcome
    Constance Delaugerre
    EA 3620 MRT, Descartes University, Paris, France
    Retrovirology 6:85. 2009
  9. doi request reprint Late postnatal HIV infection in children born to HIV-1-infected mothers in a high-income country
    Pierre Frange
    Unite d immunologie, Hématologie et Rhumatologie pédiatriques, Hopital Necker, Paris, France
    AIDS 24:1771-6. 2010
  10. pmc Evaluation of nevirapine dosing recommendations in HIV-infected children
    Frantz Foissac
    EA 3620 Université Paris Descartes Sorbonne Paris Cité, Unité de RechercheClinique, Hôpital Tarnier, 89 rue d Assas, Paris, France
    Br J Clin Pharmacol 76:137-44. 2013

Collaborators

Detail Information

Publications18

  1. ncbi request reprint Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF/ANRS CO10)
    C Dollfus
    Assistance Publique Hopitaux de Paris AP HP, Service d hématologie et d oncologie pédiatrique, Hopital d Enfants Armand Trousseau, Le Kremlin Bicetre, France
    Clin Infect Dis 51:214-24. 2010
    ..Given the limited therapeutic options available during the early years of these patients' lives and the challenge presented by treatment adherence during adolescence, the long-term outcomes among this population are encouraging...
  2. doi request reprint Correction of facial lipoatrophy using autologous fat transplants in HIV-infected adolescents
    C Dollfus
    Hopital Trousseau, Paris, France
    HIV Med 10:263-8. 2009
    ..We evaluated the patient satisfaction, safety and cosmetic results of HIV-infected adolescents who experienced autologous fat transplants for the correction of facial lipoatrophy...
  3. ncbi request reprint [The role of chelating agents in childhood lead poisoning]
    Catherine Dollfus
    Service d hématologie et d oncologie pédiatrique, hôpital d enfants Armand Trousseau 75571 Paris Cedex 12
    Rev Prat 58:869-70. 2008
  4. doi request reprint Prevention of mother-to-child HIV transmission: similar access for sub-Sahara African immigrants and for French women?
    Carine Jasseron
    INSERM Unit 822, Le Kremlin Bicetre, Paris, France
    AIDS 22:1503-11. 2008
    ..To investigate whether mother-to-child transmission (MTCT) management and rate differed between African immigrants and French-born women delivering in France...
  5. doi request reprint No relation between in-utero exposure to HAART and intrauterine growth retardation
    Nelly Briand
    INSERM, U822, Le Kremlin Bicetre, France
    AIDS 23:1235-43. 2009
    ..The use of HAART during pregnancy is now standard care to prevent mother-to-child HIV transmission in developed countries. There is controversy about its impact on low birth weight...
  6. doi request reprint Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?
    Jeanne Sibiude
    CESP INSERM U1018, Le Kremlin Bicetre, Colombes, France
    Clin Infect Dis 54:1348-60. 2012
    ..We explored this question, focusing on the initiation of ritonavir-boosted protease inhibitors (PIs) during pregnancy, which is now standard care...
  7. ncbi request reprint Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort
    Josiane Warszawski
    INSERM, U822, IFR 60, Le Kremlin Bicetre, France
    AIDS 22:289-99. 2008
    ..To identify factors associated with mother-to-child HIV-1 transmission (MTCT) from mothers receiving antenatal antiretroviral therapy...
  8. pmc Perinatal acquisition of drug-resistant HIV-1 infection: mechanisms and long-term outcome
    Constance Delaugerre
    EA 3620 MRT, Descartes University, Paris, France
    Retrovirology 6:85. 2009
    ..Primary-HIV-1-infection in newborns that occurs under antiretroviral prophylaxis that is a high risk of drug-resistance acquisition. We examine the frequency and the mechanisms of resistance acquisition at the time of infection in newborns...
  9. doi request reprint Late postnatal HIV infection in children born to HIV-1-infected mothers in a high-income country
    Pierre Frange
    Unite d immunologie, Hématologie et Rhumatologie pédiatriques, Hopital Necker, Paris, France
    AIDS 24:1771-6. 2010
    ..To evaluate the risk of late postnatal HIV-1 infection in nonbreastfed children enrolled in the French ANRS Cohort CO01 (EPF)...
  10. pmc Evaluation of nevirapine dosing recommendations in HIV-infected children
    Frantz Foissac
    EA 3620 Université Paris Descartes Sorbonne Paris Cité, Unité de RechercheClinique, Hôpital Tarnier, 89 rue d Assas, Paris, France
    Br J Clin Pharmacol 76:137-44. 2013
    ..The aims of this study were to investigate the population pharmacokinetics of NVP in children, establish factors that influence NVP pharmacokinetics and evaluate the current dosing recommendations...
  11. ncbi request reprint Serum adiponectin and leptin concentrations in HIV-infected children with fat redistribution syndrome
    Rasa Verkauskiene
    INSERM Unite, Hopital Robert Debre, Paris, France
    Pediatr Res 60:225-30. 2006
    ..In conclusion, HIV-infected children with symptoms of fat redistribution have decreased levels of adiponectin, associated with insulin resistance and dyslipidemia...
  12. ncbi request reprint Early versus deferred antiretroviral multidrug therapy in infants infected with HIV type 1
    Albert Faye
    Pediatrie Generale, hôpital R Debré, Paris, France
    Clin Infect Dis 39:1692-8. 2004
    ..The clinical impact of early antiretroviral multidrug therapy on the risk of early-onset severe human immunodeficiency virus (HIV) disease has not been evaluated on a large scale...
  13. ncbi request reprint Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?
    Nelly Briand
    Inserm U1018, Centre for research in Epidemiology and Population Health, Universite Paris Sud, Paris, France
    Clin Infect Dis 57:903-14. 2013
    ..We identified maternal and obstetrical characteristics related to lack of intravenous ZDV and compared its association with MTCT rate and other infant parameters, according to various risk factors...
  14. ncbi request reprint Association between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the French perinatal cohort study (ANRS CO1/CO11)
    Jeanne Sibiude
    Hopital Louis Mourier, Assistance Publique Hopitaux de Paris, Colombes, France Centre de Recherche en Épidémiologie et Santé des Populations, Inserm U1018, Le Kremlin Bicetre, France
    PLoS Med 11:e1001635. 2014
    ..We estimated the prevalence of birth defects in children born to HIV-infected women receiving ART during pregnancy, and assessed the independent association of birth defects with each antiretroviral (ARV) drug used...
  15. ncbi request reprint Longitudinal evaluation and risk factors of lipodystrophy and associated metabolic changes in HIV-infected children
    Marta Beregszaszi
    INSERM Unit 690, Hopital Robert Debre, Paris, France
    J Acquir Immune Defic Syndr 40:161-8. 2005
    ..To assess the rate of progression of lipodystrophy and the associated metabolic disturbances over a 2-year period in children and to assess risk factors associated with lipodystrophy and metabolic disturbances...
  16. pmc Population pharmacokinetics of atazanavir/ritonavir in HIV-1-infected children and adolescents
    Frantz Foissac
    EA 3620 Université Paris Descartes, Paris, France
    Br J Clin Pharmacol 72:940-7. 2011
    ..To investigate atazanavir (ATV) population pharmacokinetics in children and adolescents, establish factors that influence ATV pharmacokinetics and investigate the ATV exposure after recommended doses...
  17. ncbi request reprint Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort
    Béatrice Barret
    INSERM U569 Epidémiologie, Démographie et Sciences Sociales Hôpital Bicêtre AP HP, Le Kremlin Bicetre, France
    AIDS 17:1769-85. 2003
    ..Antiretroviral prevention of mother to child HIV-1 is established but tolerance remains to be assessed. AIM To determine the risk for persistent mitochondrial dysfunction in HIV-uninfected children born to seropositive mothers...
  18. ncbi request reprint Early multitherapy including a protease inhibitor for human immunodeficiency virus type 1-infected infants
    Albert Faye
    Service d Hémato immunologie, Hĵpital R Debré, Paris, France
    Pediatr Infect Dis J 21:518-25. 2002
    ..To assess tolerance and efficacy of early multitherapy including a protease inhibitor for infants perinatally infected with HIV...